主页文献库搜索
Assessment of erythroid dysplasia by "difference from normal" in routine clin...

Eidenschink Brodersen(Lisa),Menssen(Andrew... Cytometry B Clin Cytom 0000-00-00

...JAK2 positive myeloproliferative neoplasms (MPN), 5 nutritional deficiencies] were processed by NH Cl lysis and Ficoll p...

Activation of Janus kinase/signal transducers and activators of transcription...

Gonzalez-Villalva(Adriana),Piñon-Zarate(Ga... Toxicol Ind Health 0000-00-00

...JAK2 (JAK2 ph), STAT3 (STAT3 ph), STAT5, and Mpl were identified in mice spleen megakaryocytes by cytofluorometry and im...

Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel t...

Poussin(Karine),Pilati(Camilla),Couchy(Gab... Oncoimmunology 0000-00-00

...JAK2 or tyrosine kinase 2. In support of this notion, AG490, a tyrosine kinase inhibitor that selectively blocks JAK2, h...

Xinqin exhibits the anti-allergic effect through the JAK2/STAT5 signaling pat...

Zhang(Qian),Xiong(Ying),Li(Guo-Bing),Tang(... J Ethnopharmacol 0000-00-00

...JAK2), signal transduction and activator of transcription 5 (STAT5) and suppressor of cytokine signaling 3 (SOCS3) were ...

JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold D...

Hedl(Matija),Proctor(Deborah D),Abraham(Cl... J Immunol 0000-00-00

...JAK2 expression and nucleotide-binding oligomerization domain 2-induced JAK2 phosphorylation relative to AA carriers. In...

[Actualities in the management of primary myelofibrosis].

Simon(Zsófia),Marton(Imelda),Borbényi(Zita... Orv Hetil 0000-00-00

...JAK2 inhibitor ruxolitinib has become available in Hungary since 2015. Beside its high efficacy in spleen volume and in ...

[Methylation Status of the SOCS3 Gene Promoter in H2228 Cells and 
EML4-ALK-p...

Liu(Chunlai),Li(Yongwen),Dong(Yunlong),Zha... Zhongguo Fei Ai Za Zhi 0000-00-00

...JAK2-STAT signaling pathway. The aim of this study is to investigate the methylation status of the SOCS3 promoter in EML...

Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyri...

Phuangsawai(Oraphan),Beswick(Paul),Ratanab... Eur J Med Chem 0000-00-00

...JAK2 and EGFR were undertaken. We identified compound 5n and 5m as sub-micromolar inhibitors, with equivalent anti-malar...

Development of TG101348 for the treatment of JAK2-driven malignancies.

Hood(J),Cao(J),Chow(C),Doukas(J),Hanna(E),... J Clin Oncol 0000-00-00

...JAK2-induced clinical symptoms in vitro and in vivo in models utilizing primary and cultured cells in which JAK2 is acti...

Association of proliferation and apoptosis resistance in polycythemia vera er...

Laubach(J),Fu(P),Jiang(X),Arcasoy(M O) J Clin Oncol 0000-00-00

7086 Background: Polycythemia vera (PV), a myeloproliferative disorder associated with JAK2 mutation, is characterized b...

上一页 738 739 740 741 742 743 744 下一页 742 / 共 744

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]